Huckaby Pharmacal, Inc. – Trademark Portfolio

Entity Type: 03

Huckaby Pharmacal, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include Z-TUSS and STAHIST. The owner is based in LaGrange, KY.

104 E. Main Street

LaGrange, KY 40031

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Z-TUSS
Z-TUSS
Registered 1995
MUCOBID
MUCOBID
Abandoned 1991
STAVENT
STAVENT
Abandoned 1991
STAGESIC
STAGESIC
Cancelled 1991
STATUSS
STATUSS
Cancelled 1991
STAHIST
STAHIST
Registered 1991
STAMOIST
STAMOIST
Cancelled 1991

Trademark Classifications

Huckaby Pharmacal, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Huckaby Pharmacal, Inc. have?

Huckaby Pharmacal, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 3 cancelled.

What trademark classes does Huckaby Pharmacal, Inc. file in?

Huckaby Pharmacal, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Huckaby Pharmacal, Inc.'s most well-known trademarks?

Huckaby Pharmacal, Inc.'s registered trademark portfolio includes well-known marks such as Z-TUSS and STAHIST. These are among 2 currently registered trademarks in the portfolio.

What is Huckaby Pharmacal, Inc.'s trademark registration success rate?

Huckaby Pharmacal, Inc. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.